Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. März 2025 14:09 ET | Quelle: University Hospital Foundation

Successful Heart Month campaign adds $952,409 to the $3.11 million University Hospital Foundation raised for cardiac care in 2024/25

Edmonton, AB, March 11, 2025 (GLOBE NEWSWIRE) -- February was Heart Month, a nationally recognized time to raise awareness for cardiac disease. Throughout the month, the University Hospital...
18. Dezember 2023 15:41 ET | Quelle: Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research (FSR) awards $100,000 in support of cardiac sarcoidosis

The Foundation for Sarcoidosis Research (FSR) awards $100,000 in support of cardiac sarcoidosis.
12. Mai 2023 06:30 ET | Quelle: Transparency Market Research

Defibrillator Market to Reach New Heights, Predicted to Surpass USD 16.3 Bn by 2031 Due to Rising Incidence of Cardiac Disease – Global Analysis by Transparency Market Research

Wilmington, Delaware, United States, May 12, 2023 (GLOBE NEWSWIRE) -- The global defibrillators market was valued at USD 7.2 Bn in 2021 and is projected to reach USD 16.3 Bn by 2031 growing at a...
04. August 2020 09:00 ET | Quelle: Allied Market Research

Global Peripheral Artery Disease Market to Reach $5.71Billion by 2027: AMR

Portland, OR, Aug. 04, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the global peripheral artery disease market generated $3.52billion in 2019, and is...
27. Oktober 2015 21:07 ET | Quelle: Mesoblast

Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions

NEW YORK and MELBOURNE, Australia, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that the United States Patent and Trademark Office (USPTO) has granted a...
06. Oktober 2015 07:00 ET | Quelle: Akers Biosciences Inc.

Akers Biosciences Commercializes New App-Enabled Tests for Health and Wellness Industry and Consumers

THOROFARE, N.J., Oct. 6, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a medical device company focused on reducing the cost of healthcare...